David W. Newstrom

机构：Gilead Sciences (United States)

发表论文 10 篇 · 总被引 432 次 · h-index 4

代表论文

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation (2020 · Journal of Hepatology · 被引 230)
An Estrogen-Responsive Module in the Ventromedial Hypothalamus Selectively Drives Sex-Specific Activity in Females (2014 · Cell Reports · 被引 171)
Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis (2021 · BMC Rheumatology · 被引 15)
efficacy of an Ask1 Inhibitor to Reduce Fibrosis and Steatosis in a Murine Model of Nash is Associated with Normalization of Lipids and Hepatic Gene Expression and a Reduction in Serum Biomarkers of Inflammation and Fibrosis : 1359 (2015 · Hepatology · 被引 6)
ACC inhibitor demonstrates potent anti-fibrotic activity in vitro and in vivo (2018 · Journal of Hepatology · 被引 2)
Combination of an FXR agonist and an ACC inhibitor increases anti-fibrotic efficacy in rodent models of NASH (2018 · Journal of Hepatology · 被引 2)